State Street’s iKang Healthcare Group, Inc. KANG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-718,037
| Closed | -$14.6M | – | 3800 |
|
|
2018
Q4 | $14.6M | Sell |
718,037
-76,046
| -10% | -$1.35M | ﹤0.01% | 2203 |
|
|
2018
Q3 | $14.4M | Buy |
794,083
+640,542
| +417% | +$12.3M | ﹤0.01% | 2398 |
|
|
2018
Q2 | $3.14M | Buy |
153,541
+1,400
| +0.9% | +$28.2K | ﹤0.01% | 3074 |
|
|
2018
Q1 | $3.04M | Sell |
152,141
-2,956
| -2% | -$49.7K | ﹤0.01% | 3004 |
|
|
2017
Q4 | $2.45M | Buy |
155,097
+15,844
| +11% | +$229K | ﹤0.01% | 3110 |
|
|
2017
Q3 | $1.88M | Buy |
139,253
+12,667
| +10% | +$169K | ﹤0.01% | 3228 |
|
|
2017
Q2 | $1.55M | Sell |
126,586
-1,923
| -1% | -$27.9K | ﹤0.01% | 3235 |
|
|
2017
Q1 | $1.88M | Buy |
128,509
+8,502
| +7% | +$140K | ﹤0.01% | 3104 |
|
|
2016
Q4 | $2.08M | Buy |
120,007
+27,927
| +30% | +$473K | ﹤0.01% | 3089 |
|
|
2016
Q3 | $1.67M | Buy |
92,080
+3,580
| +4% | +$65.9K | ﹤0.01% | 3044 |
|
|
2016
Q2 | $1.62M | Buy |
88,500
+33,700
| +61% | +$678K | ﹤0.01% | 3107 |
|
|
2016
Q1 | $1.2M | Buy |
54,800
+16,300
| +42% | +$340K | ﹤0.01% | 3173 |
|
|
2015
Q4 | $786K | Buy |
+38,500
| New | +$664K | ﹤0.01% | 3261 |
|
State Street's KANG Position: Q1 2019 in Review
State Street sold out of iKang Healthcare Group, Inc. (KANG) in Q1 2019, closing a stake of 718,037 shares — an estimated $14.6M sold.
State Street first reported a position in KANG in Q4 2015 and held it in 13 quarters. The position peaked at $14.6M in Q4 2018. 0 funds tracked by Wall St. Rank hold KANG as of Q1 2019.
- State Street reported no remaining iKang Healthcare Group, Inc. position as of Q1 2019 after selling out during the quarter.
- State Street sold 718,037 iKang Healthcare Group, Inc. shares in Q1 2019, an estimated $14.6M.
- State Street first reported a position in iKang Healthcare Group, Inc. in Q4 2015 and held it in 13 quarters.
- State Street's iKang Healthcare Group, Inc. position peaked at $14.6M in Q4 2018.
- 0 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q1 2019.
Based on State Street's 13F filing for Q1 2019, filed 15 May 2019.